Insulin secretion and action in noninsulin-dependent diabetes mellitus. Is insulin resistance secondary to hypoinsulinemia? - PubMed (original) (raw)
Insulin secretion and action in noninsulin-dependent diabetes mellitus. Is insulin resistance secondary to hypoinsulinemia?
G M Reaven et al. Am J Med. 1983.
Abstract
The insulin-stimulated glucose metabolic clearance rate, assessed by the insulin clamp technique, was compared in 40 normal subjects and 40 age- and weight-matched patients with noninsulin-dependent diabetes mellitus. These studies were conducted at steady-state plasma insulin levels of approximately 100 microU/ml, and the mean (+/- standard error of the mean) glucose metabolic clearance rate of patients with noninsulin-dependent diabetes mellitus was 81 +/- 9 ml/m2 per minute, as compared with a value of 235 +/- 14 ml/m2 per minute for normal subjects. This difference was highly statistically significant (p less than 0.001) and documents the extreme resistance to insulin-stimulated glucose utilization seen in noninsulin-dependent diabetes mellitus. Patients with noninsulin-dependent diabetes mellitus were also shown to have a lower than normal plasma insulin response to an oral glucose challenge. In contrast, ambient plasma insulin concentrations of normal subjects and patients with noninsulin-dependent diabetes mellitus were found to be quite comparable when measured throughout the day in response to the ingestion of conventional mixed meals. Consequently, absolute hypoinsulinemia is not characteristic of patients with noninsulin-dependent diabetes mellitus under conditions of daily living. Finally, the ability of intensive insulin treatment to improve insulin resistance was studied after one and six weeks of therapy. These results indicated that successful control of hyperglycemia led to a significant improvement in insulin action as early as one week after the initiation of insulin therapy, with no further changes noted after prolonged insulin administration. The degree to which insulin action approached normal values was greater when studies were carried out at circulating insulin levels of approximately 2,000 microU/ml as compared with insulin levels of approximately 100 microU/ml, but in both instances insulin-treated diabetic patients remained insulin-resistant as compared with normal subjects. These results have corroborated the fact that abnormalities of both insulin action and secretion can be documented in patients with noninsulin-dependent diabetes mellitus. However, patients with noninsulin-dependent diabetes mellitus were not found to be absolutely hypoinsulinemic in their daily existence, and control of their hyperglycemia with exogenous insulin did not restore insulin-stimulated glucose utilization to normal. Consequently, these data are not consistent with the view that the insulin resistance in noninsulin-dependent diabetes mellitus is entirely a secondary consequence of the hypoinsulinemia presumed to be present in these patients.
Similar articles
- Can insulin resistance exist as a primary defect in noninsulin-dependent diabetes mellitus?
Swislocki AL, Donner CC, Fraze E, Chen YD, Reaven GM. Swislocki AL, et al. J Clin Endocrinol Metab. 1987 Apr;64(4):778-82. doi: 10.1210/jcem-64-4-778. J Clin Endocrinol Metab. 1987. PMID: 3546354 - Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal.
Andrews WJ, Vasquez B, Nagulesparan M, Klimes I, Foley J, Unger R, Reaven GM. Andrews WJ, et al. Diabetes. 1984 Jul;33(7):634-42. doi: 10.2337/diab.33.7.634. Diabetes. 1984. PMID: 6376219 - Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary?
Reaven GM. Reaven GM. Diabetes Care. 1984 May-Jun;7 Suppl 1:17-24. Diabetes Care. 1984. PMID: 6376025 Review. - Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus.
Ivy JL. Ivy JL. Sports Med. 1997 Nov;24(5):321-36. doi: 10.2165/00007256-199724050-00004. Sports Med. 1997. PMID: 9368278 Review.
Cited by
- Subcellular distribution of GLUT 4 in the skeletal muscle of lean type 2 (non-insulin-dependent) diabetic patients in the basal state.
Vogt B, Mühlbacher C, Carrascosa J, Obermaier-Kusser B, Seffer E, Mushack J, Pongratz D, Häring HU. Vogt B, et al. Diabetologia. 1992 May;35(5):456-63. doi: 10.1007/BF02342444. Diabetologia. 1992. PMID: 1325931 - Plasma insulin concentration is useful to guide glucose supplement in insulin overdose.
Lee P, Greenfield JR, Center JR, Campbell LV. Lee P, et al. Intensive Care Med. 2009 Jan;35(1):181-2. doi: 10.1007/s00134-008-1233-2. Epub 2008 Aug 6. Intensive Care Med. 2009. PMID: 18682916 No abstract available. - Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes.
Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, Meelheim D, Dohm GL. Caro JF, et al. J Clin Invest. 1987 May;79(5):1330-7. doi: 10.1172/JCI112958. J Clin Invest. 1987. PMID: 3033021 Free PMC article. - Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus patients.
Mosthaf L, Vogt B, Häring HU, Ullrich A. Mosthaf L, et al. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4728-30. doi: 10.1073/pnas.88.11.4728. Proc Natl Acad Sci U S A. 1991. PMID: 1711209 Free PMC article. - Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity.
Caro JF, Ittoop O, Pories WJ, Meelheim D, Flickinger EG, Thomas F, Jenquin M, Silverman JF, Khazanie PG, Sinha MK. Caro JF, et al. J Clin Invest. 1986 Jul;78(1):249-58. doi: 10.1172/JCI112558. J Clin Invest. 1986. PMID: 3522628 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical